Novartis India Ltd

NSE: NOVARTIND · BSE: 500672 · Pharmaceuticals & Biotechnology · 34 announcements

Share price: ₹2,010.50
Market cap: ₹4,964 Cr
Revenue (annual): ₹354.3 Cr
Net profit (annual): ₹93.18 Cr
P/E (TTM): 50.8×Sector 47.4×
Promoter holding: 70.68%+0.00% QoQ
FII holding: 0.15%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

23 Jul 2026 12:55 IST BSE

Novartis India Q1 FY27 Results: Net Profit ₹32.2 Cr, Up 16.7% YoY

Novartis India Ltd reported revenue from operations of ₹103.8 Cr (+18.6% YoY) and net profit of ₹32.2 Cr (+16.7% YoY) for Q1 FY27.

Key figure: Net profit ₹32.2 Cr · +16.7% YoY

Open full results → Read the filing ↗

12 May 2026 14:07 IST BSE

Financial Results

Novartis India Q4 FY26 Results: Net Profit ₹25.2 Cr, Down 14.0% YoY

Novartis India Ltd reported revenue from operations of ₹90.5 Cr (+7.9% YoY) and net profit of ₹25.2 Cr (-14.0% YoY) for Q4 FY26.

Key figure: Net profit ₹25.2 Cr · -14.0% YoY

Open full results → Read the filing ↗

12 May 2026 14:06 IST BSE

Financial Results

Novartis India Financial Results

Novartis India approved its audited financial results for the year ended March 31, 2026. The board declared an unmodified audit opinion, signaling stable financial reporting standards.

Read the filing ↗

9 Apr 2026 01:18 IST BSE

Financial Results

Novartis India Q3 FY26 Results: Net Profit ₹16.1 Cr, Down 36.6% YoY

Novartis India Ltd reported net profit of ₹16.1 Cr (-36.6% YoY) for Q3 FY26.

Key figure: Net profit ₹16.1 Cr · -36.6% YoY

Open full results → Read the filing ↗